Furthermore, HPV 16 oncoproteins E6 and E7, are known to induce activation of the PI3K/Akt pathway and have been directly linked to the pathogenesis of HPV(+) HNSCC and its resistance to the standard of care agent, cisplatin [42–45]. This evidence concerns the gene AKT1 and head and neck squamous cell carcinoma.